4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-008509
EVP & Chief R & QA Officer gave up 4,437 shares (to pay taxes)
- EVP & Chief R & QA Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Clark Mitchall G. EVP & Chief R & QA Officer | 2018-02-06 | Grant or award | +25,000 | 188,054 | D | ||
| Clark Mitchall G. EVP & Chief R & QA Officer | 2018-02-06 | Shares withheld for taxes | −4,437 | $35.80 | $158,845 | 183,617 | D |
| Derivatives | |||||||
| Clark Mitchall G. EVP & Chief R & QA Officer | 2018-02-06 | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | D | ||
Loading xslF345X03/doc4.xml…